GMED
Globus Medical, Inc. Class A Common Stock (GMED) Stock Valuation
Review Globus Medical, Inc. Class A Common Stock (GMED) valuation with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Price to earnings
- 19.96
- Price to book
- 2.57
- BTI fair market cap
- $12.89B
- Premium or discount
- -19.99%
- Market cap
- $10.31B
Globus Medical, Inc. Class A Common Stock (GMED) Stock Valuation research
The Globus Medical, Inc. Class A Common Stock valuation page presents the available multiples, profitability measures and BTI fair-value context for GMED. Valuation should be compared with the company's growth, margins, balance sheet and relevant peers rather than judged by one multiple.
A premium may reflect stronger expected growth or quality, while a discount can reflect risk or weak expectations. Neither condition alone establishes that a stock is attractive or unattractive.
BTI fair value is a model estimate, not a quoted market price. The underlying assumptions and valuation date must be checked in the valuation tool before using the premium or discount. A missing multiple must not be interpreted as zero cost or zero risk.